fbpx
Wikipedia

Pulmonary venoocclusive disease

Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension caused by progressive blockage of the small veins in the lungs.[2] The blockage leads to high blood pressures in the arteries of the lungs, which, in turn, leads to heart failure. The disease is progressive and fatal, with median survival of about 2 years from the time of diagnosis to death.[3] The definitive therapy is lung transplantation.[4]

Pulmonary veno-occlusive disease
Other namesObstructive disease of the pulmonary veins[1]
Pulmonary veno-occlusive disease-Intimal fibrosis with marked narrowing of lumen of a large pulmonary vein
SpecialtyPulmonology, cardiology 
SymptomsShortness of breath, fatigue[2]
CausesNarrow pulmonary vein, Pulmonary artery hypertension[2]
Diagnostic methodChest x-ray, Chest CT[2]
TreatmentVasodilators can be used[2]

Signs and symptoms edit

 
Cyanosis

The symptoms for pulmonary veno-occlusive disease are the following:[2][5]

Cause edit

The genetic cause of pulmonary veno-occlusive disease is mutations in EIF2AK4 gene. Though this does not mean other possible causes do not exist, such as viral infection and risk of toxic chemicals (chemotherapy drugs).[6]

Pathophysiology edit

Pulmonary veno-occlusive disease may have a genetic basis. Published reports have indicated fatal occurrences that appeared to possess a familial pattern, more to the point, a germline mutation.[7] The pathophysiology of veno-occlusive disease culminates in occlusion of the pulmonary blood vessels. This could be due to edematous tissue (sclerotic fibrous tissue). Thickening is identified in lobular septal veins, also dilatation of lymphatics happens. Furthermore, alveolar capillaries become dilated (due to back-pressure).[8]

Diagnosis edit

Pulmonary veno-occlusive disease can only be well diagnosed with a lung biopsy. CT scans may show characteristic findings such as ground-glass opacities in centrilobular distribution, and mediastinal lymphadenopathy, but these findings are non-specific and may be seen in other conditions. However, pulmonary hypertension (revealed via physical examination), in the presence of pleural effusion (done via CT scan) usually indicates a diagnosis of pulmonary veno-occlusive disease. The prognosis indicates usually a 2-year (24 month) life expectancy after diagnosis.[9][10]

Treatment edit

 
The technique of Lung transplant, the definitive therapy of PVOD.

Treatments for primary pulmonary hypertension such as prostacyclins and endothelin receptor antagonists can be fatal in people with PVOD due to the development of severe pulmonary edema, and worsening symptoms after initiation of these medications may be a clue to the diagnosis of pulmonary veno-occlusive disease.[7]

The definitive therapy is lung transplantation, though transplant rejection is always a possibility, in this measures must be taken in terms of appropriate treatment and medication.[11][12]

Epidemiology edit

Pulmonary venoocclusive disease is rare, difficult to diagnose, and probably frequently misdiagnosed as idiopathic pulmonary arterial hypertension. Prevalence in parts of Europe is estimated to be 0.1-0.2 cases per million.[13]

PVOD appears to occur as frequently in men as in women, and age at diagnosis ranges from 7–74 years with a median of 39 years.[13] PVOD may occur in patients with associated diseases such as HIV, bone marrow transplantation, and connective tissue diseases.[13] PVOD has also been associated with several chemotherapy regimens such as bleomycin, BCNU, and mitomycin.[13]

Society edit

References edit

  1. ^ "Pulmonary venoocclusive disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 31 July 2019.
  2. ^ a b c d e f "Pulmonary veno-occlusive disease: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-11-07.
  3. ^ Escribano (2012). "Survival in pulmonary hypertension in Spain: insights from the Spanish registry". Eur Respir J. 40 (3): 596–603. doi:10.1183/09031936.00101211. PMID 22362843.
  4. ^ Ye (2011). "Lengthy Diagnostic Challenge in a Rare Case of Pulmonary Veno-Occlusive Disease: Case Report and Review of the Literature". Intern Med. 50 (12): 1323–7. doi:10.2169/internalmedicine.50.5035. PMID 21673470.
  5. ^ Zander, Dani S.; Farver, Carol F. (2008-01-01). Pulmonary Pathology. Elsevier Health Sciences. p. 121. ISBN 978-0-443-06741-9.
  6. ^ "Pulmonary veno-occlusive disease". Genetics Home Reference. 2015-11-02. Retrieved 2015-11-07.
  7. ^ a b Montani, David (2010). "Pulmonary veno-occlusive disease: Recent progress and current challenges". Respiratory Medicine. 104: S23–S32. doi:10.1016/j.rmed.2010.03.014. PMID 20456932.
  8. ^ "Pulmonary Veno-Occlusive Disease: Background, Pathophysiology, Etiology". 2018-10-30. {{cite journal}}: Cite journal requires |journal= (help)
  9. ^ Light, Richard W. (2007-01-01). Pleural Diseases. Lippincott Williams & Wilkins. p. 128. ISBN 9780781769570.
  10. ^ Grosse, Claudia; Grosse, Alexandra (2010-11-01). "CT Findings in Diseases Associated with Pulmonary Hypertension: A Current Review". RadioGraphics. 30 (7): 1753–1777. doi:10.1148/rg.307105710. ISSN 0271-5333. PMID 21057119.
  11. ^ "Pulmonary Veno-Occlusive Disease Treatment & Management: Approach Considerations, Specific PAH Therapies, Immunosuppressants, Steroids, and Antithrombotic Agents". 2018-10-30. {{cite journal}}: Cite journal requires |journal= (help)
  12. ^ "Lung Transplantation: MedlinePlus". www.nlm.nih.gov. Retrieved 2015-11-07.
  13. ^ a b c d Montani (2009). "Pulmonary veno-occlusive disease". Eur Respir J. 33 (1): 189–200. doi:10.1183/09031936.00090608. PMID 19118230.
  14. ^ Phull, Hardeep (July 26, 2016). "She's tethered to an oxygen tank, but her singing career is soaring". New York Post.
  15. ^ Insdorf, Annette (November 10, 2013). "The Challenges of Chloe Temtchine". The Huffington Post.

Further reading edit

  • Montani, David; Lau, Edmund M.; Dorfmüller, Peter; Girerd, Barbara; Jaïs, Xavier; Savale, Laurent; Perros, Frederic; Nossent, Esther; Garcia, Gilles; Parent, Florence; Fadel, Elie; Soubrier, Florent; Sitbon, Olivier; Simonneau, Gérald; Humbert, Marc (2016). "Pulmonary veno-occlusive disease". The European Respiratory Journal. 47 (5): 1518–1534. doi:10.1183/13993003.00026-2016. ISSN 1399-3003. PMID 27009171.
  • Lung Diseases—Advances in Research and Treatment: 2013 Edition. ScholarlyEditions. 2013-06-21. ISBN 9781481677332.
  • Mandel, Jess; Mark, Eugene J.; Hales, Charles A. (2000-11-01). "Pulmonary Veno-occlusive Disease". American Journal of Respiratory and Critical Care Medicine. 162 (5): 1964–1973. doi:10.1164/ajrccm.162.5.9912045. ISSN 1073-449X. PMID 11069841.

External links edit

pulmonary, venoocclusive, disease, pulmonary, veno, occlusive, disease, pvod, rare, form, pulmonary, hypertension, caused, progressive, blockage, small, veins, lungs, blockage, leads, high, blood, pressures, arteries, lungs, which, turn, leads, heart, failure,. Pulmonary veno occlusive disease PVOD is a rare form of pulmonary hypertension caused by progressive blockage of the small veins in the lungs 2 The blockage leads to high blood pressures in the arteries of the lungs which in turn leads to heart failure The disease is progressive and fatal with median survival of about 2 years from the time of diagnosis to death 3 The definitive therapy is lung transplantation 4 Pulmonary veno occlusive diseaseOther namesObstructive disease of the pulmonary veins 1 Pulmonary veno occlusive disease Intimal fibrosis with marked narrowing of lumen of a large pulmonary veinSpecialtyPulmonology cardiology SymptomsShortness of breath fatigue 2 CausesNarrow pulmonary vein Pulmonary artery hypertension 2 Diagnostic methodChest x ray Chest CT 2 TreatmentVasodilators can be used 2 Contents 1 Signs and symptoms 2 Cause 3 Pathophysiology 4 Diagnosis 5 Treatment 6 Epidemiology 7 Society 8 References 9 Further reading 10 External linksSigns and symptoms edit nbsp CyanosisThe symptoms for pulmonary veno occlusive disease are the following 2 5 Shortness of breath Fatigue Fainting Hemoptysis Difficulty breathing lying flat Chest pain Cyanosis Hepatosplenic congestionCause editThe genetic cause of pulmonary veno occlusive disease is mutations in EIF2AK4 gene Though this does not mean other possible causes do not exist such as viral infection and risk of toxic chemicals chemotherapy drugs 6 Pathophysiology editPulmonary veno occlusive disease may have a genetic basis Published reports have indicated fatal occurrences that appeared to possess a familial pattern more to the point a germline mutation 7 The pathophysiology of veno occlusive disease culminates in occlusion of the pulmonary blood vessels This could be due to edematous tissue sclerotic fibrous tissue Thickening is identified in lobular septal veins also dilatation of lymphatics happens Furthermore alveolar capillaries become dilated due to back pressure 8 Diagnosis editPulmonary veno occlusive disease can only be well diagnosed with a lung biopsy CT scans may show characteristic findings such as ground glass opacities in centrilobular distribution and mediastinal lymphadenopathy but these findings are non specific and may be seen in other conditions However pulmonary hypertension revealed via physical examination in the presence of pleural effusion done via CT scan usually indicates a diagnosis of pulmonary veno occlusive disease The prognosis indicates usually a 2 year 24 month life expectancy after diagnosis 9 10 Treatment edit nbsp The technique of Lung transplant the definitive therapy of PVOD Treatments for primary pulmonary hypertension such as prostacyclins and endothelin receptor antagonists can be fatal in people with PVOD due to the development of severe pulmonary edema and worsening symptoms after initiation of these medications may be a clue to the diagnosis of pulmonary veno occlusive disease 7 The definitive therapy is lung transplantation though transplant rejection is always a possibility in this measures must be taken in terms of appropriate treatment and medication 11 12 Epidemiology editPulmonary venoocclusive disease is rare difficult to diagnose and probably frequently misdiagnosed as idiopathic pulmonary arterial hypertension Prevalence in parts of Europe is estimated to be 0 1 0 2 cases per million 13 PVOD appears to occur as frequently in men as in women and age at diagnosis ranges from 7 74 years with a median of 39 years 13 PVOD may occur in patients with associated diseases such as HIV bone marrow transplantation and connective tissue diseases 13 PVOD has also been associated with several chemotherapy regimens such as bleomycin BCNU and mitomycin 13 Society editChloe Temtchine American singer songwriter with PVOD 14 15 References edit Pulmonary venoocclusive disease Genetic and Rare Diseases Information Center GARD an NCATS Program rarediseases info nih gov Retrieved 31 July 2019 a b c d e f Pulmonary veno occlusive disease MedlinePlus Medical Encyclopedia www nlm nih gov Retrieved 2015 11 07 Escribano 2012 Survival in pulmonary hypertension in Spain insights from the Spanish registry Eur Respir J 40 3 596 603 doi 10 1183 09031936 00101211 PMID 22362843 Ye 2011 Lengthy Diagnostic Challenge in a Rare Case of Pulmonary Veno Occlusive Disease Case Report and Review of the Literature Intern Med 50 12 1323 7 doi 10 2169 internalmedicine 50 5035 PMID 21673470 Zander Dani S Farver Carol F 2008 01 01 Pulmonary Pathology Elsevier Health Sciences p 121 ISBN 978 0 443 06741 9 Pulmonary veno occlusive disease Genetics Home Reference 2015 11 02 Retrieved 2015 11 07 a b Montani David 2010 Pulmonary veno occlusive disease Recent progress and current challenges Respiratory Medicine 104 S23 S32 doi 10 1016 j rmed 2010 03 014 PMID 20456932 Pulmonary Veno Occlusive Disease Background Pathophysiology Etiology 2018 10 30 a href Template Cite journal html title Template Cite journal cite journal a Cite journal requires journal help Light Richard W 2007 01 01 Pleural Diseases Lippincott Williams amp Wilkins p 128 ISBN 9780781769570 Grosse Claudia Grosse Alexandra 2010 11 01 CT Findings in Diseases Associated with Pulmonary Hypertension A Current Review RadioGraphics 30 7 1753 1777 doi 10 1148 rg 307105710 ISSN 0271 5333 PMID 21057119 Pulmonary Veno Occlusive Disease Treatment amp Management Approach Considerations Specific PAH Therapies Immunosuppressants Steroids and Antithrombotic Agents 2018 10 30 a href Template Cite journal html title Template Cite journal cite journal a Cite journal requires journal help Lung Transplantation MedlinePlus www nlm nih gov Retrieved 2015 11 07 a b c d Montani 2009 Pulmonary veno occlusive disease Eur Respir J 33 1 189 200 doi 10 1183 09031936 00090608 PMID 19118230 Phull Hardeep July 26 2016 She s tethered to an oxygen tank but her singing career is soaring New York Post Insdorf Annette November 10 2013 The Challenges of Chloe Temtchine The Huffington Post Further reading editMontani David Lau Edmund M Dorfmuller Peter Girerd Barbara Jais Xavier Savale Laurent Perros Frederic Nossent Esther Garcia Gilles Parent Florence Fadel Elie Soubrier Florent Sitbon Olivier Simonneau Gerald Humbert Marc 2016 Pulmonary veno occlusive disease The European Respiratory Journal 47 5 1518 1534 doi 10 1183 13993003 00026 2016 ISSN 1399 3003 PMID 27009171 Lung Diseases Advances in Research and Treatment 2013 Edition ScholarlyEditions 2013 06 21 ISBN 9781481677332 Mandel Jess Mark Eugene J Hales Charles A 2000 11 01 Pulmonary Veno occlusive Disease American Journal of Respiratory and Critical Care Medicine 162 5 1964 1973 doi 10 1164 ajrccm 162 5 9912045 ISSN 1073 449X PMID 11069841 External links edit nbsp Scholia has a topic profile for Pulmonary venoocclusive disease Retrieved from https en wikipedia org w index php title Pulmonary venoocclusive disease amp oldid 1089470992, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.